Ultra-high-dose methylcobalamin demonstrates safety in advanced ALS, but intramuscular administration poses practical burdens and its selected study cohort limits generalizability

Journal of the Neurological Sciences 2026

View at publisher

Authors: Mingxia Zhang, Yujie Zhang, Yuting Pu, Xue Bai

DOI: 10.1016/j.jns.2026.125838

Cited by: 0

References: 5

Fields of Study & Subjects

Amyotrophic Lateral Sclerosis Research Botulinum Toxin and Related Neurological Disorders Peripheral Neuropathies and Disorders

References 5